Department of Psychiatry, Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Psychol Med. 2022 Oct;52(14):3184-3192. doi: 10.1017/S0033291720005279. Epub 2021 Jan 14.
Genotype-first and within-family studies can elucidate factors that contribute to psychiatric illness. Combining these approaches, we investigated the patterns of influence of parental scores, a high-impact variant, and schizophrenia on dimensional neurobehavioral phenotypes implicated in major psychiatric disorders.
We quantitatively assessed cognitive (FSIQ, VIQ, PIQ), social, and motor functioning in 82 adult individuals with a 22q11.2 deletion (22 with schizophrenia), and 148 of their unaffected parents. We calculated within-family correlations and effect sizes of the 22q11.2 deletion and schizophrenia, and used linear regressions to assess contributions to neurobehavioral measures.
Proband-parent intra-class correlations (ICC) were significant for cognitive measures (e.g. FSIQ ICC = 0.549, < 0.0001), but not for social or motor measures. Compared to biparental scores, the 22q11.2 deletion conferred significant impairments for all phenotypes assessed (effect sizes -1.39 to -2.07 s.d.), strongest for PIQ. There were further decrements in those with schizophrenia. Regression models explained up to 37.7% of the variance in IQ and indicated that for proband IQ, parental IQ had larger effects than schizophrenia.
This study, for the first time, disentangles the impact of a high-impact variant from the modifying effects of parental scores and schizophrenia on relevant neurobehavioral phenotypes. The robust proband-parent correlations for cognitive measures, independent of the impact of the 22q11.2 deletion and of schizophrenia, suggest that, for certain phenotypes, shared genetic variation plays a significant role in expression. Molecular genetic and predictor studies are needed to elucidate shared factors and their contribution to psychiatric illness in this and other high-risk groups.
基于基因型的研究和家系内研究可以阐明导致精神疾病的因素。我们结合这两种方法,研究了父母评分、高影响力变异体和精神分裂症对涉及主要精神障碍的多维神经行为表型的影响模式。
我们定量评估了 82 名携带 22q11.2 缺失(22 名患有精神分裂症)的成年个体以及他们 148 名未受影响的父母的认知(FSIQ、VIQ、PIQ)、社交和运动功能。我们计算了 22q11.2 缺失和精神分裂症的家系内相关性和效应大小,并使用线性回归来评估对神经行为测量的贡献。
与父母评分相比,22q11.2 缺失对所有评估的表型都有显著影响(效应大小为-1.39 至-2.07 个标准差),对 PIQ 的影响最大。患有精神分裂症的个体则进一步下降。回归模型解释了智商变异的 37.7%,表明对于个体智商,父母的智商比精神分裂症有更大的影响。
这项研究首次将高影响力变异体的影响与父母评分和精神分裂症的修饰效应分开,对相关神经行为表型进行了分析。认知测量中存在稳健的个体-父母相关性,独立于 22q11.2 缺失和精神分裂症的影响,这表明对于某些表型,共享遗传变异在表达中起着重要作用。需要进行分子遗传学和预测因子研究,以阐明这些因素及其在该群体和其他高风险群体中对精神疾病的贡献。